1. DNA lesions and mutations accumulate with progressive ageing {#sec0005}
===============================================================

There is substantial evidence for an ageing associated accumulation of DNA damage in various tissues despite the presence of different types of repair systems ([Figs. 1 and 2](#fig0005 fig0010){ref-type="fig"}; [@bib0145; @bib0255; @bib0265]). Markers of DNA damage accumulate in skin of ageing baboons ([@bib0220]), in stem and progenitor cells of ageing murine intestine ([@bib0225]) as well as in ageing haematopoietic stem (HSC) and progenitor cells from mice and humans ([@bib0330; @bib0340]). Although γH2AX foci in quiescent aged HSCs have recently been disputed to label sites of DNA damage ([@bib0165]), other studies demonstrate an accumulation of DNA breaks and mutations in ageing murine and human HSCs ([@bib0025; @bib0055; @bib0115; @bib0455; @bib0470]).

Accumulating mutations at stem and progenitor cell level appear to contribute to ageing associated defects in organ maintenance and an increase in cancer development ([@bib0430]). Recently, whole genome sequencing approaches in the haematopoietic system revealed an age-associated increase of mutations in human HSCs and provided insight into the clonal evolution of mutations and development of leukaemia ([@bib0055; @bib0115; @bib0455; @bib0470]). The data suggest that mutations are acquired in a lifelong random manner, and that most mutations behave as neutral 'passengers' at HSC level until an additional 'driver' mutation supports clonal amplification of a subset of passenger mutations ([@bib0455]). The initial driver mutation may only support increased self-renewal ([@bib0055]), but may still depend on additional 'driver' hits to transform the HSC into a leukaemic stem cell ([Fig. 3](#fig0015){ref-type="fig"}; [@bib0455]). Similarly, it could be demonstrated that individual driver mutations in male germline stem cells contribute a selective advantage to the affected cells allowing the clonal amplification and inheritance of the mutations ([@bib0185; @bib0190]). It remains to be determined whether mutations in stem cells accumulate in a simple stochastic manner or whether ageing associated exponential dynamics of mutation accumulation occur. Given some evidence that checkpoint function may decline with age ([@bib0160]) and that older HSC reveal slower *in vitro* DNA damage repair ([@bib0340]) it is possible to assume a progressive increase of mutation accumulation during ageing. The mechanisms that drive ageing associated increases in mutation accumulation in stem cells represents an emerging research field that could include cell intrinsic and extrinsic factors ([@bib0135]).

2. A reduced capacity to repair DNA leads to stem cell depletion {#sec0010}
================================================================

It is conceivable that the accumulation of lesions and mutations observed during ageing of HSCs may in part be caused by acquired defects in DNA repair pathways ([Fig. 2](#fig0010){ref-type="fig"}). Germline mutations affecting DNA repair factors cause an increasing accumulation of DNA lesions and have the potential to cause progeria syndromes thus linking DNA damage accrual to progressive ageing. Classic examples are Werner syndrome, Hutchinson-Guilford disease or Cockayne syndrome ([@bib0050; @bib0230; @bib0105]), while additional progeria susceptibility factors, such as SPRTN are being discovered ([@bib0275]). Defective DNA repair can furthermore be directly linked to a premature exhaustion of the stem cell pool of certain tissues. A dysfunctional Fanconi anemia (FA) pathway, which repairs interstrand crosslinks (ICL) causes a premature failure of bone marrow haematopoiesis in humans. This is due to an accumulation of DNA lesions resulting in an overstimulation of DNA damage checkpoint responses in HSCs and their progenitors ([@bib0065]). Interestingly, lack of ICL repair recently was shown to sensitize murine HSCs to damage caused by endogenous aldehydes ([@bib0180]). In addition to the data on the requirement of ICL repair for stem cell maintenance, studies on mice deficient for nucleotide excision repair demonstrate a critical role also for this pathway in HSC maintenance and prevention of premature ageing ([Fig. 2](#fig0010){ref-type="fig"}; [@bib0330]).

HSC maintenance is furthermore affected by experimental manipulation targeting nonhomologous endjoining (NHEJ), which leads to defects in the haematopoietic reserve (demonstrated by mutation of Ligase 4, DNA dependent protein kinase catalytic subunit (DNA-PKcs), or loss of XRCC4-like factor (XLF)/Cernunnos; [@bib0020; @bib0305; @bib0490; @bib0330; @bib0335]; [@bib0330]). However, also other organ compartments seem to rely on NHEJ, since reduced expression of Ku80 caused accelerated ageing of the skeletal muscle and muscle stem cells also known as satellite cells ([@bib0140]). NHEJ repairs double strand breaks (DSBs) by mediating the ligation of broken DNA ends after only minimal processing ([@bib0450]). In contrast to homologous recombination (HR), which also repairs DSBs and helps to restart stalled replication forks, NHEJ does not require a template and is thus considered error-prone. However, this independence of a template uncouples NHEJ from the cell cycle allowing execution of repair also during G0/G1. Since HSCs usually are quiescent and divide only rarely, they predominantly use NHEJ to repair DSBs ([@bib0300]). Although preferential use of the error-prone NHEJ allows quick repair of DSBs, this bears the risk of an elevated mutation rate. Recent evidence showed that DNA damage can remain unrepaired in quiescent HSCs possibly explaining an ageing associated DNA damage accrual. Furthermore, upon entry into the cell cycle, HR becomes available for repair ([@bib0025]). In addition, HSCs harbouring non-repairable DNA damage, such as dysfunctional telomeres, are depleted by apoptosis upon cell cycle activation or blocked from cell cycle entry by induction of senescence ([@bib0445]). Both mechanisms (employment of HR as a repair pathway and blockage/removal of non-repairable HSCs) likely contribute to lower the risk of mutation accumulation in ageing HSCs. However, emerging data on the accumulation of genome mutation in ageing human HSCs indicate that DNA damage surveillance and protection mechanisms are not perfect and fail during ageing ([@bib0055]). In contrast to the studies on DNA repair deficient mouse models and progeria syndromes in humans ([@bib0230]), relatively little is known about the evolution of DNA repair deficiencies during 'physiological ageing' and how this may affect the maintenance of genome integrity in ageing stem cells.

3. Enhanced DNA repair in young stem cells {#sec0015}
==========================================

Some types of stem cells protect their genome by enhanced rates of DNA repair compared to more differentiated somatic cells. Hair follicle bulge stem cells in the epidermis avoid apoptosis after ionizing radiation (IR)-induced DNA damage via increased activity of NHEJ to repair DSBs ([@bib0385]). Quicker repair is accompanied by attenuated p53 activation and expression of the anti-apoptotic factor B-cell lymphoma 2 (Bcl-2), which maintains bulge stem cell number after DNA damage infliction. Recently, a similarly enhanced NHEJ capacity was reported for satellite cells, which repaired DSBs more efficiently than their progeny ([@bib0420]). Interestingly, repair was not only faster, but also more precise, since satellite cells mainly used classical NHEJ and avoided alternative NHEJ. The latter makes use of microhomologies in sequences near the break site to align broken ends while intervening sequences are degraded and lost (see later section on telomere shortening induced chromosomal fusions, [@bib0035]). Thus, the preferential use of classical NHEJ appears to contribute to enhance the maintenance of stable genomes in satellite cells ([@bib0420]). The small intestine is a highly proliferative tissue, which therefore strongly depends on functional stem cells. Subpopulations of intestinal stem cells (ISCs) seem to repair high loads of DNA damage with faster kinetics as compared to their progeny ([@bib0235]). However, in contrast to stem cells of the hair bulge or satellite cells, they make use of HR and NHEJ ([@bib0235]).

4. Prevention of DNA damage {#sec0020}
===========================

One way to protect the genome is to avoid the formation of DNA damage in the first place. HSCs follow this strategy by sustaining a hypoxic status ([@bib0315]) and by generating ATP mostly through glycolysis rather than mitochondrial respiration, which HSCs use upon cell cycle entry ([@bib0410; @bib0480]). This greatly reduces the generation of reactive oxygen species (ROS) and its associated risks of damaging DNA. Mutations that change the metabolic activity and thereby increase ROS production diminish the self-renewal capacity of HSCs ([Fig. 4](#fig0020){ref-type="fig"}; [@bib0075]). Thus, preserving the quiescent state reduces the risk to suffer damage from toxic intracellular byproducts of metabolism. Interestingly, loss of the DNA damage checkpoint kinase Ataxia telangiectasia mutated (ATM) also leads to increases in ROS, which influence cell cycle activity of HSCs. ROS reduce self-renewal by activation of the cyclin dependent kinase (CDK) inhibitor p16^Ink4a^ and the tumour suppressor Rb, and block quiescence by induction of the stress response kinase p38 ([Fig. 4](#fig0020){ref-type="fig"}; [@bib0245; @bib0250]). Furthermore, deletions of Forkhead box O (Foxo) transcription factors, which aid in detoxification of ROS, also compromise HSC self-renewal and quiescence by stimulating Rb and p53 ([@bib0295; @bib0415; @bib0475]). However, treatment with the ROS scavenger N-acetylcysteine rescues HSC maintenance ([@bib0075; @bib0245; @bib0415; @bib0475]). Collectively, the data suggests that Foxo, Rb, and p53 control the hazardous effects of moderate ROS generation during normal stem cell maintenance but that sustained activation of these pathways contributes to stem cell dysfunction.

DNA replication itself comprises the potential to induce DNA damage due to replication errors or breakage of elongating forks ([@bib0485]). Impeding the efficiency of replication by conditional ablation of the checkpoint kinase Ataxia telangiectasia and Rad3 related (ATR) or its downstream kinase Chk1 is thus problematic for maintenance of different types of stem cells and causes premature ageing phenotypes in skin, bones, small intestine, and the haematopoietic system ([Fig. 4](#fig0020){ref-type="fig"}; [@bib0350; @bib0195]). Lack of ATR or Chk1 triggers the rapid accumulation of DNA damage, which provokes p53-dependent and -independent checkpoint responses including apoptosis and cell cycle arrest ([@bib0355; @bib0195]). Similarly to the findings on HSCs, quiescence is still protective for hair follicle bulge stem cells since resting cells survive ATR deletion whereas cycling cells suffer p53-mediated deletion ([@bib0355]).

Similar to stem cells of the hair bulge, HSCs and satellite cells also generally remain quiescent and are only activated when needed ([@bib0080; @bib0460]). Consequently, loss of HSC quiescence causes accelerated depletion of stem cells ([@bib0075; @bib0175]). During ageing satellite cells and HSCs preserve a quiescent state. However, de-repression of p16^INK4a^ in satellite cells induces a permanent senescence-like state that prevents stem cell reactivation and consequently muscle regeneration ([@bib0390]). Ageing HSCs show only little change in overall cell cycle activity and a delayed cell cycle progression ([@bib0310; @bib0335]). Similarly as to aged satellite cells, this has been attributed to an upregulation of p16^INK4a^, although this has not been universally observed ([@bib0015; @bib0260]). Delayed cell cycle progression in aged HSCs could involve reduced capacity of the DNA replication machinery itself ([@bib0165]). Aged HSCs show a reduced expression of MCM4 and 6, subunits of the MCM complex, the helicase needed to establish pre-replicative complexes as well as for replication elongation. Reduced availability of the MCM complex thus could reduce origin firing during S phase and slow down fork movement, both of which has been observed in aged HSCs and was caused by knock down of MCM4 or 6 in young HSCs ([@bib0165]). Thus, inefficient DNA replication may contribute to reduce stem cell functionality in aged organisms.

5. Is there an immortal DNA strand? {#sec0025}
===================================

Another strategy to avoid mutations in stem cells is the concept of the so-called immortal strand. This idea -- which is under debate -- postulates that stem cells would specifically keep the template DNA strands in an asymmetric division. Thus, if replication-associated mutations would occur only the differentiated daughter cell would obtain mutated DNA, while the original DNA strands remain in the renewed stem cell. Label-retaining stem cells at the +4 position in crypts of the small intestine led to this hypothesis ([@bib0320]), although the mechanistic details remain to be unravelled. Some evidence supports the immortal strand concept in satellite cells ([@bib0110; @bib0380]). However, this mechanism of genome protection seems not to be relevant in ISCs and HSCs ([@bib0155; @bib0270; @bib0375; @bib0400]).

6. Destabilized telomeres, an intrinsic source of DNA damage {#sec0030}
============================================================

Eukaryotic chromosome ends are composed of highly repetitive DNA sequences, the telomeres. Progressive shortening of telomeres is observed in various ageing human organs including colonic mucosa and HSCs ([@bib0205; @bib0265; @bib0425]). Studies on telomere biology provided functional proof that the accumulation of DNA damage at chromosome ends can induce premature ageing in mice ([@bib0040; @bib0345]) and fish ([@bib0215]). Moreover, dysfunctional Werner syndrome helicase (WRN) causes premature ageing by accelerated telomere shortening ([@bib0070; @bib0120; @bib0150]). During each round of S-phase the end replication problem and processing of chromosome ends lead to loss of 50--100 terminal base pairs of linear chromosomes ([@bib0100; @bib0280]). To avoid loss of genetic information during replication and to protect chromosome ends from fusion, the long telomeric repeats are additionally associated with protective shelterin nucleoproteins ([@bib0130]). However, in human cells this buffer is limited to 7--12 kilobases and telomeres progressively shorten to critically short lengths that are then recognized as DNA damage. This evokes p53/p21 dependent checkpoint responses inducing a permanent cell cycle arrest (replicative senescence) ([Fig. 4](#fig0020){ref-type="fig"}; [@bib0045; @bib0125]).

Stem cells are protected from extended telomere loss by expression of the enzyme telomerase ([@bib0090; @bib0465]). However, the level of telomerase activity apparently is not sufficient to prevent telomere shortening in HSCs and ISCs during ageing ([@bib0375; @bib0425]). Studies on telomerase deficient mice provided the first experimental evidence that telomere shortening leads to p53/p21 dependent defects in self-renewal and functional capacity of germline stem cells ([@bib0085]) and somatic stem cells ([@bib0005; @bib0095; @bib0330; @bib0395]). The contribution of telomere shortening to the functional decline of stem cells and disease evolution during 'physiological ageing' remains to be determined. Of note, studies on wildlife bird revealed a predictive value on lifespan of both telomere length at birth and telomere shortening rates during adult life ([@bib0210; @bib0360]). Similarly, in humans, telomere length was identified as predictive marker for ageing associated diseases, cancer, and lifespan ([@bib0060]).

Cell culture experiments suggested that p53 and retinoblastoma (Rb) checkpoint networks respond to telomere dysfunction ([@bib0085; @bib0200]). Indeed, deletion of p53 rescued depletion of testicular germ cells usually observed in the telomerase (mTerc) single knockout mice ([@bib0085]). However, loss of p53 led to an increased tumour load ([@bib0010]) and accelerated the ageing of somatic tissues by enhancing survival of chromosomally instable stem cells with abnormal differentiation potential ([@bib0030]). Triggered by critically short telomeres, p53 mediates two main checkpoint responses: permanent cell cycle arrest via activation of the cell cycle dependent kinase inhibitor p21 and apoptosis by induction of the BH3-only pro-apoptotic factor Puma. Interestingly, deletion of either p21 or Puma improves stem cell and tissue maintenance in the context of dysfunctional telomeres, which elongated the lifespan of telomere dysfunctional mice without increasing tumour formation ([@bib0095; @bib0395]). These data suggested that it is possible to increase the functional stem cell reserve temporarily by blunting one branch of the p53 response without increasing the risk for genome instability and tumour formation as the other branch of the p53-pathway remains intact.

In addition to the induction of checkpoints it is conceivable that induction of DNA repair contributes to stem cell failure in response to telomere dysfunction. Along these lines it was demonstrated that exonuclease 1 (Exo1) dependent DNA end-resection of shortened telomeres contributes to the induction of DNA repair. This results in the formation of chromosomal fusions (likely induced by alternative NHEJ), which triggers subsequent checkpoint induction ([@bib0290; @bib0325; @bib0370]). Chromosomal fusions represent a major problem as they lead to amplification of DNA damage and chromosomal instability. Thus, it will be important to determine the relative contribution of checkpoints and aberrant repair to trigger stem cell and tissue ageing.

Recently, it was demonstrated that long telomeres also accumulate irreparable DNA damage ([@bib0170; @bib0225]). Compared to telomere shortening, the accumulation of DNA damage at long telomeres may not be as detrimental to stem cells and tissues since telomere binding proteins suppress the induction of checkpoints and repair responses at intra-telomeric damage sites. In future research, it will be important to better define the detrimental effects that are induced by DNA damage responses at the chromosome termini in ageing cells and how these drive the evolution of stem cell and tissue dysfunction.

7. Removal of damaged stem cells {#sec0035}
================================

Expansion of damaged stem cells is deleterious for organ maintenance and may lead to cancer formation. To this end it may be important to clear damaged stem cells from the pool of self-renewing stem cells by induction of checkpoints such as apoptosis. Increasing levels of ageing associated apoptosis are detected under homeostasis in germ cells ([@bib0435]) and HSCs ([@bib0260]) and upon external stress in small intestine crypts ([@bib0285]) involving p53-dependent and -independent processes. An alternative way to remove damaged cells from the active stem cell pool is the engagement of differentiation. IR-induced DNA damage limits the self-renewal capacity of melanocyte stem cells in the epidermal hair follicle by induction of differentiation into mature melanocytes. This leads to depletion of melanocyte stem cells and hair greying ([@bib0240]). Interestingly, deletion of ATM elevates IR-induced differentiation of melanocyte stem cells ([@bib0240]). Perhaps loss of ATM impairs self-renewal via elevated ROS in melanocyte stem cells similar to what was observed in HSCs (see above). In addition, it was recently reported that DNA damage in the haematopoietic system induces the G-CSF/STAT3 axis leading to induction of Basic leucine zipper transcription factor---ATF-like (BATF) in HSCs ([@bib0440]). This causes lymphoid-biased HSCs to differentiate, which contributes to HSC depletion and myeloid lineage bias in response to IR. Together, induction of differentiation in stem cells emerges as a novel checkpoint response preventing self-renewal of damaged tissue stem cells. Interestingly, it was recently shown that ATM is required for the prevention of differentiation and the sustained self-renewal of leukaemic stem cells in mixed lineage leukaemia (MLL)-AF9 induced leukaemia ([@bib0365]). It remains to be seen whether differentiation-inducing checkpoints contribute to the prevention of the accumulation of mutations in ageing stem cells and cancer initiation.

8. Outlook {#sec0040}
==========

There is an increasing knowledge on molecular mechanisms that are important for genome maintenance in adult tissue stem cells. However, recent data on the accumulation of genome-wide mutations and DNA damage in ageing stem cells indicate that genome maintenance mechanisms fail during ageing. Given the close interaction between the accumulation of molecular damages and gene mutations with the evolution of diseases and cancer in ageing tissues, it is one of the biggest challenges to delineate mechanisms that contribute to the failure of genome maintenance in ageing stem cells. Recent studies indicate that the role of self-renewing progenitor cells in tissue maintenance during homeostatic conditions may currently be underestimated ([@bib0405]). Therefore, it will also be important to consider differences in DNA repair in progenitor cells and stem cells and to define the role of progenitor cell DNA mutations in the evolution of ageing associated diseases. In addition, it appears to be of increasing importance to study mechanisms in the cell environment (the stem cell niche and in the circulatory environment) that may lead to an enhanced selection of mutant stem and progenitor cells during ageing. Along these lines it is interesting to note that a high percentage of ageing associated mutations in stem cells affect regulators of the epigenome ([@bib0115]), which may drive adaptive responses and clonal selection of stem cells in ageing tissues. A detailed understanding of the molecular causes of genome instability in ageing stem and progenitor cells should ultimately help to develop molecular therapies aiming to improve tissue functionalities and to prevent the evolution of ageing associated diseases thus allowing a healthier ageing.

![Stem cell maintenance is affected by cell response pathways. A given stem cell pool is able to react to external cues with a repertoire of cellular reactions. Quiescence and self-renewal of stem cells, as well as dedifferentiation of committed progenitor cells back to more primitive stem cells positively influence stem cell maintenance. Senescence, apoptosis, anoikis (detachment induced cell death), differentiation, and possibly necrosis (so far not shown at stem level) influence stem cell numbers negatively. A balanced dynamic interplay guarantees for proper stem cell maintenance. For example, an external insult causing stem cell apoptosis can be compensated for by a wave of self-renewal divisions, which is followed by re-establishment of quiescence; lack of quiescence induction and continuous self-renewal would otherwise lead to stem cell depletion. The balanced interplay seems to be affected with advancing ageing making it more difficult for the body to react properly.](gr1){#fig0005}

![Repair pathways revert distinct types of DNA lesions. On top different types of DNA lesions are highlighted, which are schematically represented in red. Indicated below is the pathway that repairs the specific subset of lesions.](gr2){#fig0010}

![A model how increased mutations could impair stem cell functionality. Young stem cells (SC) properly self-renew and generate functional progenitor cells (PC) to maintain tissue homeostasis. Aged, but still functional stem cells show accumulation of DNA lesions and passenger mutations. Driver mutations in critical genes render ageing stem cells dysfunctional. Clonal expansion of damaged stem and progenitor cells contributes to carcinogenesis, while diminished self-renewal capacities and generation of non-functional progenitor cells causes organ failure.](gr3){#fig0015}

![Checkpoint signalling influences stem cell maintenance. The tumour suppressors p53 and Rb are two central checkpoint factors influencing stem cell maintenance. Both factors interfere with cell cycle control, and p53 additionally engages the cell death machinery. Upstream DNA damage response kinases ATM and ATR sense the cell\'s damage load and relay this information towards p53 and Rb. It is the magnitude of damage that decides between permanent solutions like senescence or apoptosis, or a transient response like reversible quiescence or self-renewal suspension. In order to compensate for the loss through senescence or apoptosis stem cells need to induce self-renewal divisions, which are started through growth promoting factors. Re-establishment of quiescence is vital in this context to prevent stem cell exhaustion through continuous self-renewal divisions. Interestingly, both tumour suppressors p53 and Rb are able to protect the organism from the accumulation of stem cells with too much damage (senescence and apoptosis) and additionally preserve the quiescent stem cell pool. The dashed connections are likely to exist but experimental evidence at stem cell level is partially lacking.](gr4){#fig0020}
